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(2017), hAim: To systematically review surveys of 12-month prevalence of homeopathy use by
the general population worldwide.
Methods: Studies were identified via database searches to October 2015. Study quality
was assessed using a six-item tool. All estimates were in the context of a survey which
also reported prevalence of any complementary and alternative medicine use.
Results: A total of 36 surveys were included. Of these, 67% met four of six quality
criteria.
Twelve-month prevalence of treatment by a homeopath was reported in 24 surveys of
adults (median 1.5%, range 0.2e8.2%). Estimates for children were similar to those for
adults. Rates in the USA, UK, Australia and Canada all ranged from 0.2% to 2.9% and re-
mained stable over the years surveyed (1986e2012).
Twelve-month prevalence of all use of homeopathy (purchase of over-the-counter ho-
meopathic medicines and treatment by a homeopath) was reported in 10 surveys of
adults (median 3.9%, range 0.7e9.8%) while a further 11 surveys which did not define
the type of homeopathy use reported similar data. Rates in theUSA andAustralia ranged
from 1.7% to 4.4% and remained stable over the years surveyed. The highest use was re-
ported by a survey in Switzerland where homeopathy is covered by mandatory health
insurance.
Conclusions: This review summarises 12-month prevalence of homeopathy use from
surveys conducted in eleven countries (USA, UK, Australia, Israel, Canada, Switzerland,
Norway, Germany, South Korea, Japan and Singapore). Each year a small but significant
percentage of these general populations use homeopathy. This includes visits to homeo-
paths as well as purchase of over-the-counter homeopathic medicines. Homeopathy
(2017)-, 1e10.
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ttp://dx.doi.org/10.1016/j.homp.2017.03.002nemann.1 Hahnemann argued that medicine should follow
the principle of similitude (like cures like). Hahnemann
developed homeopathy by giving medicinal substances to
healthy volunteers and studying the symptoms which
they suffered (a process known as a ‘proving’ or a Homeo-
pathic Pathogenetic Trial). Hahnemann then applied the
medicinal substances in cases of illness which had similar
symptoms. Homeopathic medicines are created from a
wide variety of substances (e.g. plants, animals, minerals
or chemicals). In order to diminish toxicity, the medicinal
substances are diluted successively and shaken vigorously
between each dilution step.by the general population worldwide: a systematic review, Homeopathy
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HomeopThere is controversy regarding the provision of homeop-
athy in state funded healthcare systems, as many claim that
the principles on which homeopathy are based are ‘scien-
tifically implausible’.2 Despite this, treatment by homeo-
paths and the provision of homeopathic medicines
remain popular, and it is provided and/or subsidized and/
or endorsed by a number of governments worldwide,
including its provision in a number of publicly funded
healthcare systems e.g. India which has an estimated
300,000 practitioners of homeopathy3 with homeopathy
part of the Indian Ministry of Health,4 France where
43.5% of the overall population of healthcare providers
prescribe homeopathic medicines (mostly co-prescribed
with allopathic medicines) and the UK where homeopathy
has been provided by the NHS since its inception in 1948.
This study systematically reviews the data on the preva-
lence of homeopathy use by the general public worldwide.
Our review summarises prevalence data for both treatment
by a homeopath and all homeopathy use including pur-
chases of over-the-counter (OTC) homeopathic medicines.Methods
Search strategy
The systematic review followed the recommendations in
the PRISMA statement.5 The following databases were
searched in October 2015: MEDLINE via Ovid, Pubmed,
Cochrane Database of Systematic Reviews, Allied and
Complementary Medicine Database (AMED), Cumulative
Index to Nursing and Allied Health Literature (CINAHL)
and Health Management Information Consortium
(HMIC). The search strategy combined terms for: i) com-
plementary and alternative medicines, ii) prevalence, sur-
veys or patterns of use, and iii) population-level or
national-level data. The full search strategy is provided in
our previous reviews on prevalence of use of any Comple-
mentary and Alternative Medicine (CAM).6,7 The database
search was restricted to studies published from 1998
onwards. Studies published prior to 1998 were identified
from previous systematic reviews of CAM prevalence.8,9
Bibliographies of included papers were checked for
further relevant studies and experts in the field contacted.Inclusion and exclusion criteria
Studies were included if they reported 12-month preva-
lence of treatment by a homeopath and/or OTC use of ho-
meopathy, in addition to the prevalence of overall CAM use
and/or visits to CAM practitioners (the latter were inclu-
sion criteria for the broader review6). Prevalence had to
be reported over a 12-month retrospective period within a
random or representative general population sample of a
nation or a defined geographical area. Surveys of clearly-
defined age groups (such as adults, children or older adults)
were included. Studies were excluded if they were not
based on representative samples of the general population;
for example, surveys of sub-populations with specific clin-
ical conditions or socio-demographic characteristics (other
than age). Included studies used survey methods such asathy
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(2017), http://dx.doi.org/10.1016/j.homp.2017.03.002structured interviews or self-complete questionnaires.
Studies were excluded if they did not report 12-month
prevalence or were not written in English. Studies were
also excluded if the prevalence of CAM use was not ex-
pressed as a percentage of the target population (or with
data making calculations of percentage possible).Study selection and data extraction
Studies identified by the searches were assessed for in-
clusion by two reviewers. Any ambiguity was discussed
between the reviewers. Data were extracted by one
reviewer and checked by another. Again, any ambiguity
was discussed between reviewers (for example, to discern
within each article whether the term ‘homeopathy’ referred
to the homeopathic medicines or to visits/consultations
with a homeopath).Definitions of homeopathy
One challenge in data extraction was understanding
what was meant by the term ‘homeopathy’10 when surveys
asked ‘do you use homeopathy?’. The term ‘homeopathy’
has multiple possible meanings: the therapeutic system of
homeopathy, the principles of the therapeutic system of ho-
meopathy, homeopathic medicines (also known as homeo-
pathic remedies), or treatment by a homeopath. We
addressed this by reporting estimates of ‘homeopathy
use’ in three ways:
a) Treatment by a homeopath: includes survey estimates
of one or more ‘visits to’ or ‘consultations with’ a ho-
meopath.
b) All homeopathy use (OTC and treatment by homeo-
path): includes survey estimates of use of homeopathic
medicines purchased OTC and treatment by a homeo-
path.
c)Homeopathy use (not defined): survey does not define
whether estimate refers to treatment by a homeopath or
OTC use or both.Quality assessment
There is no agreed set of criteria for assessing the quality
of health-related surveys. As part of our wider systematic
review on prevalence of overall CAM use, we devised a
six-item, literature-based quality assessment tool
comprising important and assessable criteria of methodo-
logical quality.6 A revised version of this was applied to
each of the included studies.
The criteria covered by the quality assessment tool
include: 1) whether homeopathy use was clearly defined
as referring to treatment by a homeopath or OTC use or
both; 2) whether the survey was piloted (piloting was
assumed for government sponsored health surveys); 3)
whether the sample size was $1000 and/or a sample size
calculation was reported; 4) whether the reported response
rate was$60%; 5) whether data were weighted to popula-
tion characteristics to reduce non-response bias; and 6)
whether a 95% confidence interval and/or standard error
were reported for the main prevalence estimates.by the general population worldwide: a systematic review, Homeopathy
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Number of surveys included
The search for surveys on CAM use identified 3147
unique citations. Of these, 3035 were excluded at the title
and abstract stage, while the full texts of 112 references
were examined. A total of 41 references were included
in this review, reporting data from 36 independent surveys
conducted in eleven countries (USA, UK, Australia,
Israel, Canada, Switzerland, Norway, Germany, South Ko-
rea, Japan and Singapore). There were 33 surveys report-
ing data on adults, 4 reporting data for children and
adolescents, and 5 reporting data for older adults. A
PRISMA flow-chart for study selection is provided in
Figure 1.Quality of included survey reports
Based on the information reported, we assessed all sur-
vey reports using six quality criteria (Table 1). The quality
of survey reports is summarized in Table 2. Of the 39 sur-
vey reports listed in Table 1, 26 (67%) of all surveys met at
least four of six quality criteria; this was 95% for govern-
ment sponsored health surveys and 37% for non-
government surveys. Around 75% of all surveys defined
whether homeopathy use referred to treatment by a homeo-
path, OTC use or both. A sample size of $1000 wasFigure 1 PRISMA 2009 Flow Diagram e 3147 unique citations. Of thes
texts of 112 references were examined.
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(2017), http://dx.doi.org/10.1016/j.homp.2017.03.002achieved in around 90% of all surveys. Government spon-
sored surveys were more likely than non-government spon-
sored surveys to report piloting (100% vs. 42%); to achieve
a response rate of at least 60% (75% vs. 32%), toweight the
data to population characteristics (80% vs. 47%); and to
report a confidence interval and/or standard error (65%
vs. 42%).Prevalence of use of homeopathy
Table 3 presents the 12-month prevalence of homeopa-
thy use as reported in the included surveys. Survey data
are ordered by country, then survey type (government
sponsored national, other national, or sub-national), then
year of survey. Data are grouped by age: adults; children
and adolescents; and older adults. Table 4 provides a sum-
mary of the median and range for prevalence of treatment
by homeopaths and all use of homeopathy for each age
group.Treatmentbyhomeopaths
Adults
Estimates for 12-month prevalence of treatment by a ho-
meopath for adults (24 survey estimates) ranged from 0.2%
to 8.2% and the median was 1.5% (Table 4).e, 3035 were excluded at the title and abstract stage, while the full
Homeopathy
by the general population worldwide: a systematic review, Homeopathy
Table 1 Characteristics and quality assessment of survey reports of homeopathy use
Survey characteristics Quality criteria Meets $4
quality
criteriaCountry Survey type Year of
survey
Name of
survey
Reference(s) 1. Homeopathy
use defined*
2. Piloting of
survey
reported y
3. Sample size
$1000 and/or
calculation
reported (SSC)
4. Reported
response
rate $60%
(adj/unadj/
NR)
5. Data
weighted to
population
6.95% CI
and/or SE
reported
Adults
USA Govt. national 2012 NHIS Clarke (2015)11 Yes Yes (govt.
survey)
Yes (34,525) Yes 61.2%
(NR)
Yes Yes (SE) Yes
USA Govt. national 2007 NHIS Barnes (2008)12 No Yes (govt.
survey)
Yes Yes Yes Yes (SE) Yes
18+: 23,393 18+: 67.8%
(NR)
0e17: 9417 0e17: 76.5%
(NR)
USA Govt. national 202 NHIS Barnes (2004)13 No Yes (govt.
survey)
Yes (31,044) Yes 74.3%
(adj)
Yes Yes (SE) Yes
USA Govt. national 1999 NHIS Ni (2002)14 No Yes (govt.
survey)
Yes (30,801) Yes 70%
(NR)
Yes Yes (CI) Yes
USA Govt. national 1996 MEPS Druss (1999)15 Yes Yes (govt.
survey)
Yes (Age
18 + 16,068)
Yes 77.7%
(NR)
Yes No (NR) Yes
USA Govt. national 1995e6 MIDUS Honda (2005)16 No Yes (govt.
survey)
Yes (4,242) Yes 60.8%
(NR)
Yes No (NR) Yes
USA Other national 1997 Eisenburg (1998)17 Yes Yes (piloted) Yes (2055; SSC) Yes 60%
(adj); 49%
(unadj)
Yes Yes (SE) Yes
USA Other national 1997 Landmark Healthcare
(1998)18
No No (NR) Yes (1500) NR NR Yes (CI) No
USA Other national 1990 Eisenberg (1993)19 Yes Yes (piloted) Yes (1539; SSC) Yes 67%
(unadj)
Yes Yes (CI) Yes
USA Other sub-nat. 1999 Arcury (2004)20 Yes No (NR) Yes (1059) Yes 83.8%
(NR)
Yes Yes (SE) Yes
UK Govt. national 2005 HSE Hunt (2010)21 Yes Yes (govt.
survey)
Yes (7630) Yes 71%
(unadj)
NR No (NR) Yes
UK Govt. national 2001 NOS Thomas (2004)22 Yes Yes (govt.
survey)
Yes (1794) Yes 65%
(unadj)
NR Yes (CI) Yes
UK Other national 1999 Ernst (2000)23 No No (NR) Yes (1204) NR Yes No (NR) No
UK Other national 1998 Thomas (2001)24 Yes Yes (piloted) Yes (2669; SSC) No 59% (adj) Yes Yes (CI) Yes
UK Other national 1993 Thomas (1993)25 Yes Yes (piloted) No (676) Yes 78%
(adj)
Yes Yes (CI) Yes
UK Govt. sub-nat. 1986 CHS Yung (1988)26 Yes Yes (govt.
survey)
Yes (4268) Yes 70%
(adj)
NR Yes (CI) Yes
Australia Other national 2005 Xue (2007)27 Yes Yes (piloted) Yes (1067; SSC) NR Yes Yes (CI) Yes
Australia Govt. sub-nat. 2004 SAHOS MacLennan (2006)28 Yes Yes (govt.
survey)
Yes (15+: 3015) Yes 71.7%
(unadj)
Yes Yes (CI) Yes
Australia Govt. sub-nat. 2000 SAHOS MacLennan (2002)29 Yes Yes (govt.
survey)
Yes (3027) Yes 70.4%
(NR)
Yes Yes (CI) Yes
Australia Govt. sub-nat. 1993 SAHOS MacLennan (1996)30 Yes Yes (govt.
survey)
Yes (3004) Yes 73.6%
(NR)
Yes No (NR) Yes
Australia Other sub-nat. 2012 Thomson (2014)31 Yes Yes (piloted) Yes (1256) No 40.3%
(NR)
NR No (NR) No
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Israel Govt. national 2003e4 INHIS Niskar (2007)32 Yes Yes (govt.
survey)
Yes (2365) No 58.6%
(unadj)
NR No (NR) No
Israel Other sub-nat. 2000 Schmueli (2004a)33 Yes No (NR) Yes (2505) NR NR No (NR) No
Israel Other sub-nat. 1993 Schmueli (2004b)33 Yes No (NR) Yes (2003) NR NR No (NR) No
Canada Govt. national 2001e5 CCHS Metcalfe (2010)34 Yes Yes (govt.
survey)
Yes (400,055) NR Yes Yes (CI) Yes
Canada Govt. national 1994e5 NPHS Millar (1997)35 Yes Yes (govt.
survey)
Yes (17,626) NR Yes No (NR) Yes
Switzerland Govt. national 2012 SHS Klein (2015)36 Yes Yes (govt.
survey)
Yes (18,357) No 45.0%
(unadj)
Yes Yes (CI) Yes
Switzerland Govt. national 2007 SHS Klein (2012)37 Yes Yes (govt.
survey)
Yes (14,432) No 51.0%
(unadj)
Yes Yes (CI) Yes
Norway Other sub-nat. 2008 HUNT 3 Lohre (2012)38 Yes No (NR) Yes (50,827) No 54.0%
(unadj)
NR No (NR) No
Norway Other sub-nat. 1995e7 HUNT 2 Steinsbekk (2008)39 Yes No (NR) Yes (40,027) No 43.1%
(unadj)
NR No (NR) No
Germany Other sub-nat. 1997e2001 Schwarz (2008)40 Yes No (NR) Yes (4291) Yes 68.8%
(unadj)
NR No (NR) No
South Korea Other national 2006 Ock (2009)41 No No (NR) Yes (3000) No 49.8%
(unadj)
Yes No (NR) No
Japan Other national 2001 Yamashita (2002)42 No Yes (piloted) Yes (1000) NR Yes Yes (CI) Yes
Children and adolescents
USA Govt. national 2007 NHIS Barnes (2008)12 See adults section above
USA Govt. national 1996 MEPS Davis (2003), Yussman
(2004)43,44
Yes Yes (govt.
survey)
Yes (age <18:
6262)
Yes 77.7%
(NR)
Yes Yes (CI) Yes
Norway Other sub-nat. 1995e7 HUNT 2 Steinsbekk (2010)45 Yes No (NR) Yes (7888) Yes 79.4%
(unadj)
NR No (NR) No
Australia Govt. sub-nat. 2004 SAHOS Smith (2006)46 No Yes (govt.
survey)
No (age <15:
911)
Yes 71.7%
(unadj)
Yes Yes (CI) Yes
Older adults
USA Govt. national 1995e6 MIDUS Honda (2005),
McMahan (2004)16,47
See adults section above
USA Other sub-nat. 1997e8 Astin (2000)48 No No (NR) No (728) No 51%
(unadj)
NR No (NR) No
USA Other sub-nat. NR Cheung (2007)49 Yes Yes (piloted) Yes (445; SSC) No 37%
(unadj)
NR No (NR) No
Singapore Govt. national 2003e4 NMHSE Feng (2010)50 Yes Yes (govt.
survey)
Yes (1092) Yes 72.4%
(NR)
Yes No (NR) Yes
Australia Other national 2005 Xue (2007), Zhang
(2007)27,51
See adults section above
* Homeopathy use was considered to be defined if the survey specified that data related to over-the-counter use, treatment by a homeopath, or both.
y Piloting was assumed for government surveys. Abbreviations: adj = adjusted; CCHS = Canadian Community Health Survey; CI = confidence interval; HSE = Health Survey for England;
MEPS = Medical Expenditure Panel Survey; MIDUS = Midlife Development in the US; NHIS = National Health Interview Survey; NMHSE = National Mental Health Survey of the Elderly;
NOS = National Omnibus Survey; NPHS = National Population Health Survey; NR = not reported; OTC = over-the-counter purchase; SAHOS = South Australian Health Omnibus Survey;
SE = standard error; SHS = Swiss Health Survey; SSC = sample size calculation; unadj = unadjusted.
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Table 2 Summary of quality of survey reports
Quality criterion All survey
reports (n = 39)
N (%)
Govt. sponsored survey
reports (n = 20)
N (%)
Other survey
reports (n = 19)
N (%)
1. Homeopathy use measurement clearly defined* 29 (74%) 15 (75%) 14 (74%)
2. Piloting of survey reported (assumed for govt.
surveys)
28 (72%) 20 (100%) 8 (42%)
3. Sample size $1000 and/or sample size calculation
used
36 (92%) 19 (95%) 17 (89%)
4. Reported survey response rate $60% 21 (54%) 15 (75%) 6 (32%)
5. Data weighted to population characteristics 25 (64%) 16 (80%) 9 (47%)
6.95% confidence interval and/or standard error
reported
21 (54%) 13 (65%) 8 (42%)
Meets $4 quality criteria 26 (67%) 19 (95%) 7 (37%)
* Homeopathy use was considered to be defined if the survey specified that data related to over-the-counter use, treatment by a homeopath, or
both.
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HomeopThe highest estimates (6.4% and 8.2%) were reported by
surveys in Switzerland36,37 where homeopathy is covered by
mandatory health insurance. Estimates from the USA in
1990e1999 ranged from 0.2 to 0.7 (four surveys).15,17,19,20
Rates for UK surveys were similar: 0.4e1.9% (five
surveys in 1986e2005).21,22,24e26 Rates for Australia were
also similar (0.5e2.9%; five surveys in 1993e2012),27e31
as were rates for Canada (2.02.3%, two surveys in
1994e2005).34,35 In most countries, rates remained stable
over the years surveyed.Children
Estimates of treatment by a homeopath for children and
adolescents (2 surveys) were 0.03% in a USA 1996 survey
of ages 0e17 years43,44 and 2.6% in a Norway 1995e7
survey of ages 13e19 years.45Older adults
There were no estimates of treatment by a homeopath
specifically relating to older adults.Allhomeopathyuse (treatmentby
homeopathsandOTCuse)
Adults
Estimates for 12-month prevalence of all homeopathy
use by adults (treatment by homeopaths and OTC use)
was reported in 10 surveys and ranged from 0.7% to
9.8% with a median of 3.9%. A further 8 surveys did not
specify type of homeopathy use; estimates ranged from
0.1% to 5.0% (median 2.1%) (Table 4).
The highest prevalence (9.8%) was reported by a 1998
survey in England, which was the only included survey
to report separate estimates for treatment by a homeopath
(1.2%) and OTC use (8.6%)24 (Table 4). Two further UK
surveys reported rates of 3.1% (all homeopathy use)21
and 3.5% (use not defined)23 (Table 3).
Five USA government sponsored health surveys esti-
mated that between 1.7% and 3.1% of the adult population
had used homeopathy in the last 12 months.11e14,16 Rates
were similar over the years surveyed (1995e2012).
Although homeopathy use was not consistently defined inathy
Please cite this article in press as: Relton C, et al., Prevalence of homeopathy use
(2017), http://dx.doi.org/10.1016/j.homp.2017.03.002these USA surveys, the most recent report11 specified
that estimates covered both treatment by a homeopath
and OTC use, so this can probably be assumed for earlier
surveys. Rates for Australian government sponsored sur-
veys were similar: 4.4% (1993),30 4.3% (2000)29 and
2.2% (2004).28 Rates were lower in East Asian countries:
Japan (0.3% in 2001)42 and South Korea (0.1% in 2006).41
Older adults
For older adults (3 surveys), estimates of the 12-month
prevalence of all homeopathy use were 0.0% in
Singapore,50 2.5% in the USA49 and 4.6% in Australia27,51
with a median of 2.5%.
Children
Two surveys in children reported estimates of 1.3%
(USA)12 and 2.0% (Australia),46 though type of homeopa-
thy use was not defined.
Discussion
This report provides a comprehensive and systematic re-
view of surveys reporting 12-month prevalence of use of
homeopathy. This complements our previous reports which
systematically reviewed prevalence of any CAM use and
visits to any CAM practitioners,6 visits to five specific
types of CAM practitioner (acupuncturists, homeopaths,
chiropractors, osteopaths and medical herbalists),7 and
visits to massage therapists.52 The data reported here in-
cludes estimates from 36 surveys across eleven countries.
Our analysis covers both the prevalence of treatment by
a homeopath and also the prevalence of all use of homeop-
athy (over the counter use or treatment by a homeopath),
and all estimates were in the context of a survey or survey
subsection relating to health and healthcare which also re-
ported prevalence of any complementary and alternative
medicine use. The survey data indicated that the percent-
age of the adult general population using homeopathy
over the previous 12 months was in the range of
0.7e9.8%, with a median estimate of 3.9%, and the per-
centage accessing treatment by a homeopath over the pre-
vious 12 months was in the range of 0.2e8.2%, with a
median estimate of 1.5%.by the general population worldwide: a systematic review, Homeopathy
Table 3 Twelve-month prevalence of homeopathy use (treatment by homeopath and all use) by the general population across eleven countries
Survey characteristics Quality summary Estimates for prevalence of homeopathy use (%) Reference(s)
Country Survey type Year of
survey
Name of
survey
Sample
size
Sample ages
(% males)
Meets $4
quality criteria
Defines
homeopathy
use
Treatment by
homeopath
All homeopathy
use (treatment by
homeopath + OTC)
Homeopathy
use (not defined)
Adults*
USA Government national 2012 NHIS 34,525 18+ (NR) Yes Yes e 2.2 e Clarke (2015)11
2007 NHIS 23,393 18+ (NR) Yes No e e 1.8 Barnes (2008)12
2002 NHIS 31,044 18+ (NR) Yes No e e 1.7 Barnes (2004)13
1999 NHIS 30,801 18+ (NR) Yes No e e 3.1 Ni (2002)14
1996 MEPS 16,068 18+ (47) Yes Yes 0.4 e e Druss (1999)15
1995e6 MIDUS 4242 25e74 (43) Yes No e e 2.4 Honda (2005)16
USA Other national 1997 2055 18+ (48) Yes Yes 0.6 3.4 e Eisenburg (1998)17
1997 1500 18+ (NR) No No e e 5.0 Landmark (1998)18
1990 1539 18+ (52) Yes Yes 0.2 0.7 e Eisenberg (1993,
1998)17,19
USA Other sub-national 1999 1059 18+ (NR) Yes Yes 0.7 e e Arcury (2004)20
UK Government national 2005 HSE 7630 16+ (45) Yes Yes 1.7 3.1 e Hunt (2010)21
2001 NOS 1794 16+ (47) Yes Yes 1.9 e e Thomas (2004)22
UK Other national 1999 1204 18+ (45) No No e e 3.5 Ernst (2000)23
1998 2669 18+ (43) Yes Yes 1.2 9.8 e Thomas (2001)24
1993 676 18+ (47) Yes Yes 1.7 e e Thomas (1993)25
UK Government sub-national 1986 CHS 4268 18+ (NR) Yes Yes 0.4 e e Yung (1988)26
Australia Other national 2005 1067 18+ (49) Yes Yes 2.9 6.0 e Xue (2007)27
Australia Government sub-national 2004 SAHOS 3015 15+ (49) Yes Yes 0.5 2.2 e MacLennan
(2006)28
2000 SAHOS 3027 15+ (49) Yes Yes 1.2 4.3 e MacLennan
(2002)29
1993 SAHOS 3004 15+ (49) Yes Yes 1.2 4.4 e MacLennan
(1996)30
Australia Other sub-national 2012 1256 18+ (NR) No Yes 2.7 4.3 e Thomson (2014)31
Israel Government national 2003e4 INHIS 2365 21+ (44) No Yes 1.3 e e Niskar (2007)32
Israel Other sub-national 2000 2505 45e75 (47) No Yes 2.8 e e Shmueli (2004a)33
1993 2003 45e75 (48) No Yes 1.8 e e Shmueli (2004b)33
Canada Government national 2001e5 CCHS 400,055 12+ (49) Yes Yes 2.3 e e Metcalfe (2010)34
1994e5 NPHS 17,626 15+ (NR) Yes Yes 2.0 e e Millar (1997)35
Switzerland Government national 2012 SHS 18,357 15+ (48) Yes Yes 8.2 e e Klein (2015)36
2007 SHS 14,432 15+ (NR) Yes Yes 6.4 e e Klein (2012)37
Norway Other sub-national 2008 HUNT 3 50,827 20+ (45) No Yes 1.3 e e Lohre (2012)38
1995e7 HUNT 2 40,027 20+ (47) No Yes 4.3 e e Steinsbekk
(2008)39
Germany Other sub-national 1997e01 4291 20e79 (49) No Yes 1.0 e e Schwarz (2008)40
South Korea Other national 2006 3000 30e69 (50) No No e e 0.1 Ock (2009)41
Japan Other national 2001 1000 20e79 (49) Yes No e e 0.3 Yamashita (2002)42
Children and adolescents
USA Government national 2007 NHIS 9417 0e17 (NR) Yes No e e 1.3 Barnes (2008)12
1996 MEPS 6262 0e17 (52) Yes Yes 0.03 e e Davis (2003),
Yussman
(2004)43,44
Norway Other sub-national 1995e7 HUNT 2 7888 13e19 (NR) No Yes 2.6 e e Steinsbekk
(2010)45
Australia Government sub-national 2004 SAHOS 911 0e15 (46) Yes No e e 2.0 Smith (2006)46
(Continued on next page )
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(2017), http://dx.doi.org/10.1016/j.homp.2017.03.002pathy useData from our previous systematic reviews and our more
recent findings suggests that the general public (adult or
all ages) of the countries surveyed were similarly likely
to consult a homeopath (median 1.5%) as an acupuncturist
(median 1.4%), medical herbalist (median 0.9%) or osteo-
path (median 1.9%), while massage therapists (median
5.5%) and chiropractors (median 7.5%) were visited
slightly more often than homeopaths.7
There were various limitations in conducting this liter-
ature review. A limitation is that only studies reported in
the English language were included, although we
included English language reports of surveys from any
country. In 10 of 39 reports it was unclear whether a defi-
nition of homeopathy was provided to the individuals
before participation in the survey. This may have created
discrepancies in the data collected. Data was only ob-
tained from surveys which also reported overall 12-
month prevalence of any CAM use and/or visits to any
CAM practitioner. Therefore, surveys only reporting use
of homeopathy but not reporting overall CAM use or
visits were not included in this review. This is a potential
strength of this review, as data from the types of survey
included here (many of which were government spon-
sored health surveys or large population surveys) may
be expected to be of higher quality, and potentially
more representative of the general population, than data
from surveys of a single therapy.
A number of countries include homeopathy in their pub-
licly funded healthcare systems (UK, France, Italy, Ger-
many, Switzerland, India, Pakistan, Brazil, and
Mexico53), yet our review identified estimates from only
two of these countries e Switzerland (which has the high-
est estimate of treatment by a homeopath) and the UK
(which had the highest estimate of all homeopathy use).
No published English language surveys were identified in
India, where homeopathy is a popular treatment modality54
and considered part of mainstream medicine. We recom-
mend that a further review is conducted which includes
all languages.
Our stringent reviewmethods meant that rigorously con-
ducted single studies which reported homeopathy preva-
lence data (without CAM prevalence data) were excluded
even if they would have met our quality criteria. An
example of this is a high quality study of data from the
French national health insurance database (SNIIRAM).55
This study reported that 10.2% of the overall French pop-
ulation and 18% of children aged 0e4 years in France
received at least one prescription for a homeopathic medi-
cine during a 12-month period. Both figures are signifi-
cantly higher than those found in the studies included in
our review.
This review summarises 12-month prevalence of ho-
meopathy use from studies in eleven countries (USA,
UK, Australia, Israel, Canada, Switzerland, Norway, Ger-
many, South Korea, Japan and Singapore). Each year a
small but significant percentage of these general popula-
tions use homeopathy. This includes visits to homeopaths
as well as purchase of over-the-counter homeopathic
medicines.by the general population worldwide: a systematic review, Homeopathy
Table 4 Summary of twelve-month prevalence of homeopathy use
Age group Treatment by a homeopath All homeopathy use (treatment by homeopath + OTC) Homeopathy use
(not defined)
N survey
estimates
Median %
(range)
N survey
estimates
Median %
(range)
N survey
estimates
Median %
(range)
Adults 24 1.5 (0.2e8.2) 10 3.9 (0.7e9.8) 8 2.1 (0.1e5.0)
Children + adolescents 2 1.3 (0.03e2.6) 0 e 2 1.7 (1.3e2.0)
Older adults 0 e 3 2.5 (0.0e4.6) 2 3.7 (1.5e5.8)
All age groups* 26 1.5 (0.03e8.2) 12 3.3 (0.0e9.8) 11 2.0 (0.1e5.8)
* All age groups excludes “older adults” data for Honda 2005 and Xue 2007 to avoid double-counting as these participants are included within
estimates for adults.
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